National Center for Research Resources (NCRR)
539
5
9
412
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
6.5%
35 terminated/withdrawn out of 539 trials
92.2%
+5.7% vs industry average
16%
84 trials in Phase 3/4
31%
128 of 412 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (539)
Long-Term Follow-Up of Recipient of Gene Transfer Research
Role: collaborator
Chromosome 18 Clinical Research Center
Role: collaborator
Worldwide Sarcoidosis Research Study
Role: collaborator
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Role: collaborator
Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms
Role: collaborator
Oral Water Ingestion in Heart Transplant Patients
Role: collaborator
Sleep Actigraphy in Postural Tachycardia Syndrome (POTS)
Role: collaborator
Acute Salt Handling in Orthostatic Intolerance
Role: collaborator
THRIVE: Culturally AdapTed Harm Reduction Intervention
Role: collaborator
Maternal Body Composition Regulates Placental Function
Role: lead
TrialNet Pathway to Prevention of T1D
Role: collaborator
Hydrocortisone for BPD
Role: collaborator
Follow-up Visit of High Risk Infants
Role: collaborator
Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
Role: collaborator
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Role: collaborator
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
Role: collaborator
Acetaminophen and Social Processes
Role: collaborator
Soy Isoflavones and Breast Cancer Risk Reduction
Role: collaborator
Mindful Eating and Living for Obese Women
Role: collaborator
Longitudinal Study of Urea Cycle Disorders
Role: collaborator